Jikilani, Sal .
HRN: 26-96-54 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/17/2025
CEFUROXIME 1.5GM (VIAL)
06/17/2025
06/24/2025
IV
350mg
Q8
Infectious Diarrhea
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes